e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of guidelines for community-acquired pneumonia: a story of confounders, surprises and challenges
Ewig S., Welte T.
Source:
Eur Respir J 2008; 32: 823-825
Journal Issue:
October
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ewig S., Welte T.. Evaluation of guidelines for community-acquired pneumonia: a story of confounders, surprises and challenges. Eur Respir J 2008; 32: 823-825
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Whether there are pharmacoeconomic and other advantages of using procalcitonin-guide antibacterial treatment in patients with severe community-acquired pneumonia in developing countries?
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect
Source: Eur Respir J 2012; 39: 7-8
Year: 2012
Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect
Source: Eur Respir J 2011; 39: 7-8
Year: 2012
Management of community-acquired pneumonia: new evidence-based algorithms.
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021
PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Source: Milan 2017 - Educational material
Year: 2017
Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008
Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future!
Source: Eur Respir J 2008; 31: 1150-1152
Year: 2008
From international guidelines to local guidelines for nosocomial pneumonia: what is missing?
Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Year: 2019
A local perspective on risk factors and short term outcomes in community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis
Source: Eur Respir J 2011; 37: 858-864
Year: 2011
Hot topics and current controversies in community-acquired pneumonia
Source: Breathe, 15 (3) 216; 10.1183/20734735.0205-2019
Year: 2019
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018
Year: 2018
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: Guideline 2018
Year: 2019
Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003
Treating nosocomial pneumonia: what's new
Source: ERJ Open Res, 4 (2) 00058-2018; 10.1183/23120541.00058-2018
Year: 2018
The assessment of physicians' knowledge of community-acquired pneumonia basics: KNOCAP study
Source: International Congress 2019 – Medical education
Year: 2019
Evidence-based clinical algorithms for CAP: where do we stand?
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011
Quality indicators for management of community-acquired pneumonia
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015
Barriers to adherence to key indicators of antibiotic use for community-acquired pneumonia: a qualitative study
Source: Eur Respir J 2005; 26: Suppl. 49, 258s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept